Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Onions may help reduce cancer risk and obesity-related issues.

Certain gene variations may increase the risk and severity of alopecia areata.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Male pattern baldness does not cause an increased risk of prostate cancer.

Disrupting natural body clocks increases the risk of developing type 2 diabetes.

Finasteride may lower cholesterol and slow heart disease progression.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Patients with multiple superficial venous thrombosis are at greater risk for serious complications like cancer and recurrent blood clots.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

The technique improves facial aging signs with a low risk of complications and a recovery time of about 3 weeks.